SI
Spark Investment Management LLC
13F filer · CIK 0001554871Reported Aug 10, 2026
Net buyer this quarter
13F portfolio value$51.2MU.S. long equity reported on 13F
Positions7249 new · 5 closed
Net flow last quarter+$10.3MBuys minus sells
Top 10 positions weight60.9%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026Reported Aug 10, 202672 positions | |||||
| $10.3M | 20.09% | 0.00% | Not reported | Q1 2016 | |
| $4.21M | 8.22% | 0.06% | Not reported | Q3 2013 | |
| $3.21M | 6.27% | 0.00% | Not reported | Q3 2020 | |
| $2.52M | 4.93% | 0.00% | Not reported | Q4 2020 | |
| $2.33M | 4.54% | 0.07% | Not reported | Q4 2025 | |
| $1.95M | 3.80% | 0.14% | -24.4% | Q3 2025 | |
| $1.84M | 3.58% | 0.00% | +31.6% | Q1 2026 | |
| $1.72M | 3.35% | 0.06% | -10.3% | Q1 2025 | |
| $1.69M | 3.30% | 0.12% | -36.5% | Q3 2013 | |
| $1.44M | 2.80% | 0.01% | -3.6% | Q4 2014 | |
| $1.09M | 2.13% | 0.00% | Not reported | Q3 2013 | |
| $1.09M | 2.12% | 0.20% | +23.2% | Q4 2025 | |
| $1.07M | 2.10% | 0.11% | -41.7% | Q2 2013 | |
| $1.07M | 2.10% | 0.05% | New | Q2 2026 | |
| $1.07M | 2.09% | 0.00% | Not reported | Q3 2016 | |
| $1.04M | 2.03% | 0.03% | Not reported | Q3 2015 | |
| $829K | 1.62% | 0.04% | Not reported | Q3 2013 | |
| $777K | 1.52% | 0.04% | New | Q2 2026 | |
| $774K | 1.51% | 0.01% | -42.6% | Q2 2013 | |
| $700K | 1.37% | 0.00% | -18.6% | Q2 2013 | |
| $694K | 1.35% | 0.00% | Not reported | Q3 2018 | |
| $661K | 1.29% | Not reported | Not reported | Q4 2015 | |
| $598K | 1.17% | 0.01% | New | Q2 2026 | |
| $582K | 1.14% | 0.00% | Not reported | Q3 2013 | |
| $577K | 1.13% | Not reported | Not reported | Q4 2018 | |
| $565K | 1.10% | 0.02% | -28.6% | Q3 2025 | |
| $549K | 1.07% | Not reported | +52.6% | Q1 2017 | |
| $466K | 0.91% | 0.00% | Not reported | Q2 2014 | |
| $427K | 0.83% | 0.01% | Not reported | Q2 2021 | |
| $380K | 0.74% | 0.01% | Not reported | Q2 2014 | |
| $375K | 0.73% | 0.01% | Not reported | Q4 2013 | |
| $340K | 0.66% | 0.01% | New | Q2 2026 | |
| $306K | 0.60% | 0.01% | Not reported | Q4 2018 | |
| $303K | 0.59% | 0.07% | New | Q2 2026 | |
| $267K | 0.52% | 0.00% | New | Q2 2026 | |
| $241K | 0.47% | 0.01% | New | Q2 2026 | |
| $231K | 0.45% | 0.09% | Not reported | Q4 2017 | |
| $224K | 0.44% | 0.04% | New | Q2 2026 | |
| $212K | 0.41% | 0.00% | Not reported | Q3 2015 | |
| $207K | 0.40% | 0.05% | New | Q2 2026 | |
| $191K | 0.37% | 0.04% | New | Q2 2026 | |
| $185K | 0.36% | 0.02% | New | Q2 2026 | |
| $177K | 0.35% | 0.02% | New | Q2 2026 | |
| $160K | 0.31% | 0.07% | New | Q2 2026 | |
| $145K | 0.28% | 0.03% | New | Q2 2026 | |
| $138K | 0.27% | 0.03% | Not reported | Q4 2016 | |
| $118K | 0.23% | Not reported | -63.4% | Q1 2026 | |
| $111K | 0.22% | 0.98% | -52.1% | Q1 2025 | |
| $110K | 0.22% | 0.04% | New | Q2 2026 | |
| $85.5K | 0.17% | 0.02% | Not reported | Q4 2017 | |
| Q1 2026Reported May 11, 202628 positions | |||||
| $8.99M | 21.62% | 0.00% | Not reported | Q1 2016 | |
| $3.93M | 9.44% | 0.19% | +2.9% | Q3 2013 | |
| $3.39M | 8.16% | 0.00% | Not reported | Q3 2020 | |
| $2.61M | 6.26% | 0.07% | +258.5% | Q4 2025 | |
| $2.36M | 5.68% | 0.19% | +500.0% | Q2 2013 | |
| $2.23M | 5.36% | 0.00% | Not reported | Q4 2020 | |
| $2.2M | 5.29% | 0.18% | +159.0% | Q3 2025 | |
| $1.93M | 4.63% | 0.01% | -21.3% | Q4 2014 | |
| $1.87M | 4.49% | Not reported | +36.8% | Q3 2018 | |
| $1.63M | 3.92% | 0.06% | +30.0% | Q1 2025 | |
| $1.55M | 3.73% | 0.00% | New | Q1 2026 | |
| $1.36M | 3.27% | 0.03% | +13.0% | Q2 2013 | |
| $1.03M | 2.47% | 0.16% | +11.3% | Q4 2025 | |
| $999K | 2.40% | 0.03% | -12.5% | Q3 2025 | |
| $750K | 1.80% | 0.00% | -37.7% | Q2 2013 | |
| $654K | 1.57% | 0.00% | Not reported | Q3 2016 | |
| $609K | 1.46% | 0.00% | Not reported | Q2 2014 | |
| $524K | 1.26% | Not reported | Not reported | Q4 2015 | |
| $473K | 1.14% | 0.09% | New | Q1 2026 | |
| $447K | 1.07% | 0.00% | Not reported | Q3 2013 | |
| $417K | 1.00% | Not reported | +137.5% | Q1 2017 | |
| $408K | 0.98% | 0.01% | Not reported | Q2 2021 | |
| $346K | 0.83% | Not reported | Not reported | Q2 2013 | |
| $283K | 0.68% | Not reported | New | Q1 2026 | |
| $241K | 0.58% | 0.10% | Not reported | Q4 2017 | |
| $206K | 0.50% | 0.00% | Not reported | Q2 2017 | |
| $173K | 0.42% | 2.04% | Not reported | Q1 2025 | |
| SBSVASinovac Biotech Ltd | $0 | 0.00% | 0.04% | Not reported | Q2 2013 |
| Q4 2025Reported Feb 11, 202626 positions | |||||
| $9.97M | 24.81% | 0.00% | Not reported | Q1 2016 | |
| $4.06M | 10.12% | 0.00% | Not reported | Q3 2020 | |
| $2.7M | 6.72% | 0.00% | Not reported | Q4 2020 | |
| $2.66M | 6.63% | 0.01% | -66.7% | Q3 2013 | |
| $2.3M | 5.74% | 0.18% | Not reported | Q3 2013 | |
| $2.25M | 5.61% | 0.01% | -18.4% | Q4 2014 | |
| $1.93M | 4.80% | 0.03% | -46.3% | Q2 2025 | |
| $1.76M | 4.38% | 0.02% | +35.0% | Q2 2013 | |
| $1.34M | 3.34% | Not reported | Not reported | Q3 2018 | |
| $1.29M | 3.20% | 0.00% | -19.8% | Q2 2013 | |
| $1.15M | 2.85% | 0.06% | +21.8% | Q3 2025 | |
| $925K | 2.30% | 0.05% | Not reported | Q1 2025 | |
| $871K | 2.17% | 0.01% | Not reported | Q2 2021 | |
| $784K | 1.95% | 0.03% | Not reported | Q3 2025 | |
| $740K | 1.84% | 0.00% | Not reported | Q3 2016 | |
| $595K | 1.48% | 0.14% | New | Q4 2025 | |
| $590K | 1.47% | 0.02% | New | Q4 2025 | |
| $566K | 1.41% | Not reported | Not reported | Q4 2015 | |
| $287K | 0.71% | 0.03% | Not reported | Q2 2013 | |
| $256K | 0.64% | Not reported | +18.5% | Q3 2025 | |
| $236K | 0.59% | 2.04% | Not reported | Q1 2025 | |
| $210K | 0.52% | 0.10% | Not reported | Q4 2017 | |
| $207K | 0.52% | Not reported | Not reported | Q1 2017 | |
| $42.8K | 0.11% | 0.02% | New | Q4 2025 | |
| $10.5K | 0.03% | 0.01% | New | Q4 2025 | |
| SBSVASinovac Biotech Ltd | $0 | 0.00% | 0.04% | Not reported | Q2 2013 |
| Q3 2025Reported Nov 12, 202520 positions | |||||
| $9.48M | 23.81% | 0.00% | Not reported | Q1 2016 | |
| $6.64M | 16.68% | 0.02% | +17.4% | Q3 2013 | |
| $4.89M | 12.27% | 0.00% | Not reported | Q3 2020 | |
| $3.16M | 7.94% | 0.05% | Not reported | Q2 2025 | |
| $2.67M | 6.70% | 0.00% | Not reported | Q4 2020 | |
| $2.43M | 6.11% | 0.01% | Not reported | Q4 2014 | |
| $1.6M | 4.03% | 0.00% | -36.8% | Q2 2013 | |
| $1.49M | 3.75% | 0.02% | Not reported | Q2 2013 | |
| $1.39M | 3.49% | Not reported | Not reported | Q1 2019 | |
| $1.14M | 2.87% | 0.01% | Not reported | Q2 2021 | |
| $900K | 2.26% | 0.05% | New | Q3 2025 | |
| $839K | 2.11% | 0.00% | New | Q3 2025 | |
| $718K | 1.80% | 0.10% | -29.4% | Q2 2025 | |
| $665K | 1.67% | 0.03% | New | Q3 2025 | |
| $629K | 1.58% | Not reported | Not reported | Q4 2015 | |
| $520K | 1.31% | 0.00% | Not reported | Q3 2016 | |
| $327K | 0.82% | 2.04% | Not reported | Q1 2025 | |
| $172K | 0.43% | Not reported | New | Q3 2025 | |
| $144K | 0.36% | 0.10% | Not reported | Q4 2017 | |
| SBSVASinovac Biotech Ltd | $0 | 0.00% | 0.04% | Not reported | Q2 2013 |
Premium opens every quarter this fund has filed